1.Griffith DE., Aksamit T., Brown-Elliott BA., Catanzaro A., Daley C., Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007. 175:367–416.
Article
2.Koh WJ., Kwon OJ., Yu CM., Jeon KM., Suh GY., Chung MP, et al. Recovery rate of nontuberculous mycobacteria from acid-fast- bacilli smear-positive sputum specimens. Tuberc Respir Dis. 2003. 54:22–32.
3.Park YS., Lee CH., Lee SM., Yang SC., Yoo CG., Kim YW, et al. Rapid increase of nontuberculous mycobacterial lung diseases at a tertiary referral hospital in South Korea. Int J Tuberc Lung Dis. 2010. 14:1069–71.
4.Lee JK., Kwon HY., Kwon JK., Lee HJ., Lee DW., Lee YJ, et al. Recovery rate of nontuberculous mycobacteria and the clinical course of nontuberculous mycobacterial pulmonary disease at a secondary hospital. Tuberc Respir Dis. 2009. 67:199–204.
Article
5.American Thocic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med. 2000. 161:1376–95.
6.The Development of Korean Guidelines for Tuberculosis Korea Centers for Disease Control and Prevention. ed. Korean Guidelines for Tuberculosis. 1st ed. Seoul: The Korean Academy of Tuberculosis and Respiratory Diseases;2011.
7.Daley CL., Griffith DE. Pulmonary nontuberculous mycobacterial infections. Int J Tuberc Lung Dis. 2010. 14:665–71.
8.Glassroth J. Pulmonary disease due to nontuberculous mycobacteria. Chest. 2008. 133:243–51.
Article
9.Bae E., Im JH., Kim SW., Yoon NS., Sung H., Kim MN, et al. Evaluation of combination of BACTEC mycobacteria growth indi-cator tube 960 system and Ogawa media for mycobacterial culture. Korean J Lab Med. 2008. 28:299–306.
Article
10.Kivihya-Ndugga L., van Cleeff M., Juma E., Kimwomi J., Githui W., Oskam L, et al. Comparison of PCR with the routine procedure for diagnosis of tuberculosis in a population with high prevalences of tuberculosis and human immunodeficiency virus. J Clin Microbiol. 2004. 42:1012–5.
Article
11.Centers for Disease Control and Prevention (CDC). Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb Mortal Wkly Rep. 2009. 58:7–10.
12.Mazurek GH., LoBue PA., Daley CL., Bernardo J., Lardizabal AA., Bishai WR, et al. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA. 2001. 286:1740–7.
13.Kobashi Y., Obase Y., Fukuda M., Yoshida K., Miyashita N., Oka M. Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis. Clin Infect Dis. 2006. 43:1540–6.
Article
14.Lee JY., Choi HJ., Lee H., Joung EY., Huh JW., Oh YM, et al. Recovery rate and characteristics of nontuberculous mycobacterial isolates in a university hospital in Korea. Tuberc Respir Dis. 2005. 58:385–91.
Article
15.Koh WJ., Kwon OJ., Lee KS. Diagnosis and treatment of nontuberculous mycobacterial pulmonary diseases: a Korean perspective. J Korean Med Sci. 2005. 20:913–25.
Article
16.Choi SP., Lee BK., Min JH., Kim JH. Pathogenic classification and clinical characteristics of nontuberculous mycobacterial pulmonary disease in a national tuberculosis hospital. Tuberc Respir Dis. 2005. 59:606–12.
Article